Validation of Peptest (TM) in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing

BOR S. , Capanoglu D., VARDAR R. , Woodcock A. D. , Fisher J., Dettmar P. W.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, cilt.28, ss.383-387, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 28 Konu: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.15403/jgld-335
  • Dergi Adı: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
  • Sayfa Sayıları: ss.383-387

Özet

Background & Aims: Pepsin in the gastric refluxate is a marker for a prior reflux event and rapid detection might be achieved using the Peptest (TM), an in vitro diagnostic medical device. The aim of this study was to validate the use of Peptest (TM) to reliably diagnose reflux in patients with gastro-esophageal reflux disease (GERD) and laryngopharyngeal reflux (LPR) disease diagnosed with multichannel intraluminal impedance/pHmetry (MII-pH).